Literature DB >> 25190289

Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort.

Jinxia Zhao1, Yin Su, Ru Li, Hua Ye, Qinghua Zou, Yongfei Fang, Huaxiang Liu, Xingfu Li, Jialong Guo, Liqi Bi, Fei Gu, Lingyun Sun, Yifang Mei, Zhiyi Zhang, Lina Chen, Ping Zhu, Guangtao Li, Zhuoli Zhang, Xiaomei Leng, Yan Zhao, Li Jiang, Hejian Zou, Yi Zhao, Yi Liu, Lei Li, Hongyuan Wang, Xiangyuan Liu, Zhanguo Li.   

Abstract

OBJECTIVES: To develop classification criteria for early rheumatoid arthritis (ERA) based on a large cohort of early inflammatory arthritis patients and to evaluate the performance of these criteria.
METHODS: The study population comprised a cohort of early inflammatory arthritis patients with symptom duration less than one year. Classification criteria of ERA were developed by incorporating the most sensitive or specific variables. Performance of the ERA criteria, 1987 ACR and 2010 ACR/EULAR criteria were evaluated.
RESULTS: A total of 803 patients were enrolled in this study. By the end of the one year follow-up, 514 patients were diagnosed with RA, 251 with other rheumatic diseases, and 38 patients with undifferentiated arthritis. The ERA criteria are as follows: 1) morning stiffness ≥30 minutes; 2) arthritis of 3 or more joint areas; 3) arthritis of hand joints; 4) positive RF; 5) positive anti-CCP antibody. Rheumatoid arthritis is defined by the presence of 3 or more of the criteria. The sensitivity (84.4%) of the ERA classification criteria was much higher than the 1987 ACR criteria (58.0%). In a validation cohort of early inflammatory arthritis patients, the area under the ROC curves (AUC) showed a better performance for the ERA criteria (0.906, 95%CI 0.866 to 0.945) than the 1987 ACR criteria (0.786, 95%CI 0.725 to 0.848) and the 2010 ACR/EULAR criteria (0.745, 95%CI 0.677 to 0.814).
CONCLUSIONS: A set of ERA classification criteria has been developed with good performance for early RA. It is applicable in clinical practice and research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25190289

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  A new look at rheumatology in China--opportunities and challenges.

Authors:  Zhan-Guo Li
Journal:  Nat Rev Rheumatol       Date:  2015-01-20       Impact factor: 20.543

2.  [Clinical characteristics of psoriatic arthritis with positive rheumatoid factor or anti-cyclic citrullinated peptide antibody].

Authors:  L Y Dai; D D Gong; J X Zhao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

3.  Diagnostic value of serum connective tissue growth factor in rheumatoid arthritis.

Authors:  Jiaqi Ren; Lin Sun; Xing Sun; Zhenzhen Ma; Xinyu Wang; Zhuo An; Jinxia Zhao
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980

4.  Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort.

Authors:  Hua Ye; Yin Su; Ru Li; Jinxia Zhao; Xiangyuan Liu; Yifang Mei; Zhiyi Zhang; Jialong Guo; Liqi Bi; Xia Liu; Guochun Wang; Jinjing Liu; Xiaomei Leng; Fei Gu; Lingyun Sun; Qinghua Zou; Yongfei Fang; Quan Jiang; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2016-04-29       Impact factor: 2.980

5.  Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes.

Authors:  Yuki Inoue; Takehisa Ogura; Naoko Yamashita; Sayaka Takenaka; Hideki Ito; Ayako Hirata; Takaharu Katagiri; Yuto Takakura; Chihiro Imaizumi; Kennosuke Mizushina; Munetsugu Imamura; Rie Kujime; Norihide Hayashi; Hideto Kameda
Journal:  Intern Med       Date:  2022-07-01       Impact factor: 1.282

6.  Xanthomatosis in bilateral hands mimicking rheumatoid arthritis: A case report.

Authors:  Dan Li; Longfei You; Songqing Fan; Lihua Tan
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  LC-MS/MS-Based Serum Protein Profiling for Identification of Candidate Biomarkers in Pakistani Rheumatoid Arthritis Patients.

Authors:  Sidrah Jahangir; Peter John; Attya Bhatti; Muhammad Muaaz Aslam; Javaid Mehmood Malik; James R Anderson; Mandy J Peffers
Journal:  Life (Basel)       Date:  2022-03-21

8.  Increased expression of CXCL2 in ACPA-positive rheumatoid arthritis and its role in osteoclastogenesis.

Authors:  X Wang; L Sun; N He; Z An; R Yu; C Li; Y Li; Y Li; X Liu; X Fang; J Zhao
Journal:  Clin Exp Immunol       Date:  2020-10-21       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.